Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma

被引：0
|
作者：
Tim A. Labeur
R. Bart Takkenberg
Heinz-Josef Klümpen
Otto M. van Delden
机构：
[1] Cancer Center Amsterdam,Department of Medical Oncology, Amsterdam University Medical Centers
[2] University of Amsterdam,Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers
[3] University of Amsterdam,Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers
[4] University of Amsterdam,undefined
来源：
CardioVascular and Interventional Radiology | 2019年 / 42卷
关键词：
Hepatocellular carcinoma; Transarterial chemoembolization; TACE; Discontinuation; Time to untreatable progression by chemoembolization; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：230 / 238
页数：8
相关论文
共 50 条
  • [1] Reason of Discontinuation after Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
    Labeur, Tim
    Takkenberg, Bart
    Klumpen, Heinz-Josef
    Van Delden, Otto
    HEPATOLOGY, 2018, 68 : 840A - 841A
  • [2] Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
    Labeur, Tim A.
    Takkenberg, R. Bart
    Klumpen, Heinz-Josef
    van Delden, Otto M.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 42 (02) : 230 - 238
  • [3] Correction to: Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
    Tim A. Labeur
    R. Bart Takkenberg
    Heinz-Josef Klümpen
    Otto M. van Delden
    CardioVascular and Interventional Radiology, 2019, 42 : 484 - 484
  • [4] Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma (vol 42, pg 230, 2019)
    Labeur, Tim A.
    Takkenberg, R. Bart
    Klumpen, Heinz-Josef
    van Delden, Otto M.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 42 (03) : 484 - 484
  • [5] Transarterial chemoembolization in patients with hepatocellular carcinoma: Predictors of survival
    Sawhney, Summit
    Montano-Loza, Aldo J.
    Salat, Peter
    McCarthy, Mairin
    Kneteman, Norman
    Meza-Junco, Judith
    Owen, Richard
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2011, 25 (08): : 426 - 432
  • [6] STAGE MIGRATION AFTER TRANSARTERIAL CHEMOEMBOLIZATION AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Kassab, Ihab
    Singal, Amit G.
    Ali, Aamir
    Narasimman, Manasa
    Arvind, Ashwini
    Ahmed, Muneeb
    Joshi, Sagar
    Manzoor, Komal
    Rich, Nicole E.
    Chen, Vincent L.
    Zhao, Zhe
    Sarwar, Ammar
    Parikh, Neehar D.
    GASTROENTEROLOGY, 2022, 162 (07) : S1161 - S1161
  • [7] STAGE MIGRATION AFTER TRANSARTERIAL CHEMOEMBOLIZATION AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Kassab, Ihab
    Joshi, Sagar
    Singal, Amit G.
    Chen, Vincent L.
    Parikh, Neehar D.
    GASTROENTEROLOGY, 2021, 160 (06) : S809 - S809
  • [8] Selective and sequential transarterial chemoembolization: Survival in patients with hepatocellular carcinoma
    Antoch, Gerald
    Roelle, Grit
    Ladd, Susanne C.
    Kuehl, Hilmar
    Heusner, Till A.
    Sotiropoulos, Georgios C.
    Hilgard, Philip
    Forsting, Michael
    Verhagen, Ruediger
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (09) : 2290 - 2297
  • [9] Association of transarterial chemoembolization with survival in patients with unresectable hepatocellular carcinoma
    Wang, Peng
    Sheng, Lili
    Wang, Guoxiang
    Wang, Heping
    Huang, Xinyu
    Yan, Xiaoxing
    Yang, Xiaohua
    Pei, Renguang
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (02) : 203 - 206
  • [10] Predictors of survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization
    Doan, P. L.
    O'Neil, B. H.
    Moore, D. T.
    Bernard, S. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345